Literature DB >> 9769327

A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor.

I Beau1, P Touraine, G Meduri, A Gougeon, A Desroches, C Matuchansky, E Milgrom, F Kuttenn, M Misrahi.   

Abstract

A single natural loss of function mutation of the follicle stimulating hormone receptor (FSHR) has been described to date. Present in the Finnish population it markedly impairs receptor function, blocking follicle development at the primary stage and presenting as primary amenorrhea with atrophic ovaries. When Western European women with this phenotype were examined for FSHR mutations the result was negative, suggesting that other etiologies corresponding to this clinical pattern are markedly more frequent. We now describe a novel phenotype related to mutations provoking a partial loss of function of the FSHR. A woman with secondary amenorrhea had very high plasma gonadotropin concentrations (especially FSH), contrasting with normal sized ovaries and antral follicles up to 5 mm at ultrasonography. Histological and immunohistochemical examination of the ovaries showed normal follicular development up to the small antral stage and a disruption at further stages. The patient was found to carry compound heterozygotic mutations of the FSHR gene: Ile160Thr and Arg573Cys substitutions located, respectively, in the extracellular domain and in the third intracellular loop of the receptor. The mutated receptors, when expressed in COS-7 cells, showed partial functional impairment, consistent with the clinical and histological observations: the first mutation impaired cell surface expression and the second altered signal transduction of the receptor. This observation suggests that a limited FSH effect is sufficient to promote follicular growth up to the small antral stage. Further development necessitates strong FSH stimulation. The contrast between very high FSH levels and normal sized ovaries with antral follicles may thus be characteristic of such patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769327      PMCID: PMC508982          DOI: 10.1172/JCI3795

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle.

Authors:  T Tamura; J Kitawaki; T Yamamoto; Y Osawa; S Kominami; S Takemori; H Okada
Journal:  J Endocrinol       Date:  1992-12       Impact factor: 4.286

2.  Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome.

Authors:  D Bick; B Franco; R J Sherins; B Heye; L Pike; J Crawford; A Maddalena; B Incerti; A Pragliola; T Meitinger; A Ballabio
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245

3.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

4.  Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism.

Authors:  L C Layman; D P Cohen; M Jin; J Xie; Z Li; R H Reindollar; S Bolbolan; D P Bick; R R Sherins; L W Duck; L C Musgrove; J C Sellers; J D Neill
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

5.  A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia.

Authors:  L Laue; S M Wu; M Kudo; A J Hsueh; G B Cutler; J E Griffin; J D Wilson; C Brain; A C Berry; D B Grant
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

Review 6.  The lutropin/choriogonadotropin receptor ... 4 years later.

Authors:  D L Segaloff; M Ascoli
Journal:  Endocr Rev       Date:  1993-06       Impact factor: 19.871

Review 7.  Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis.

Authors:  S G Hillier
Journal:  Hum Reprod       Date:  1994-02       Impact factor: 6.918

8.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.

Authors:  K Aittomäki; J L Lucena; P Pakarinen; P Sistonen; J Tapanainen; J Gromoll; R Kaskikari; E M Sankila; H Lehväslaiho; A R Engel; E Nieschlag; I Huhtaniemi; A de la Chapelle
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene.

Authors:  H Kremer; R Kraaij; S P Toledo; M Post; J B Fridman; C Y Hayashida; M van Reen; E Milgrom; H H Ropers; E Mariman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

10.  Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone.

Authors:  C H Matthews; S Borgato; P Beck-Peccoz; M Adams; Y Tone; G Gambino; S Casagrande; G Tedeschini; A Benedetti; V K Chatterjee
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

View more
  44 in total

Review 1.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age.

Authors:  Kristel M van Asselt; Helen S Kok; Hein Putter; Cisca Wijmenga; Petra H M Peeters; Yvonne T van der Schouw; Diederick E Grobbee; Egbert R te Velde; Sietse Mosselman; Peter L Pearson
Journal:  Am J Hum Genet       Date:  2004-02-04       Impact factor: 11.025

3.  Novel Inactivating Mutation of the FSH Receptor in Two Siblings of Indian Origin With Premature Ovarian Failure.

Authors:  S Katari; M A Wood-Trageser; H Jiang; E Kalynchuk; R Muzumdar; S A Yatsenko; A Rajkovic
Journal:  J Clin Endocrinol Metab       Date:  2015-04-15       Impact factor: 5.958

Review 4.  Mutations in human gonadotropin and gonadotropin-receptor genes.

Authors:  I T Huhtaniemi; A P N Themmen
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

5.  A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.

Authors:  Matthew S Bramble; Ellen H Goldstein; Allen Lipson; Tuck Ngun; Ascia Eskin; Jason E Gosschalk; Lara Roach; Neerja Vashist; Hayk Barseghyan; Eric Lee; Valerie A Arboleda; Daniel Vaiman; Zafer Yuksel; Marc Fellous; Eric Vilain
Journal:  Hum Reprod       Date:  2016-02-23       Impact factor: 6.918

6.  Silencing of Fshr occurs through a conserved, hypersensitive site in the first intron.

Authors:  Brian P Hermann; Leslie L Heckert
Journal:  Mol Endocrinol       Date:  2005-04-07

Review 7.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

8.  An unbalanced translocation unmasks a recessive mutation in the follicle-stimulating hormone receptor (FSHR) gene and causes FSH resistance.

Authors:  Amla Kuechler; Berthold P Hauffa; Angela Köninger; Gunnar Kleinau; Beate Albrecht; Bernhard Horsthemke; Jörg Gromoll
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

9.  Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(-/-) FORKO mice.

Authors:  M Ghadami; E El-Demerdash; S A Salama; A A Binhazim; A E Archibong; X Chen; B R Ballard; M R Sairam; A Al-Hendy
Journal:  Mol Hum Reprod       Date:  2010-01-19       Impact factor: 4.025

10.  Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls.

Authors:  Raja Brauner; Anu Bashamboo; Sébastien Rouget; Marie Goulet; Pascal Philibert; Hélène Sarda-Thibault; Christine Trivin; Micheline Misrahi; Charles Sultan; Ken McElreavey
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.